1.
Clin Lymphoma Myeloma Leuk
; 14(2): e55-8, 2014 Apr.
Article
in English
| MEDLINE
| ID: mdl-24393621
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Burkitt Lymphoma/drug therapy , Epstein-Barr Virus Infections/diagnosis , Hodgkin Disease/diagnosis , Lymphoma, Large B-Cell, Diffuse/diagnosis , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Aged , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Cyclophosphamide/administration & dosage , Cyclophosphamide/adverse effects , Dexamethasone/administration & dosage , Dexamethasone/adverse effects , Doxorubicin/administration & dosage , Doxorubicin/adverse effects , Epstein-Barr Virus Infections/chemically induced , Epstein-Barr Virus Infections/virology , Female , Herpesvirus 4, Human/physiology , Hodgkin Disease/chemically induced , Hodgkin Disease/virology , Host-Pathogen Interactions , Humans , Lymphoma, Large B-Cell, Diffuse/chemically induced , Lymphoma, Large B-Cell, Diffuse/virology , Male , Middle Aged , Time Factors , Vincristine/administration & dosage , Vincristine/adverse effects
2.
J Clin Oncol
; 29(6): e138-40, 2011 Feb 20.
Article
in English
| MEDLINE
| ID: mdl-21135275